Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

Bolli, Niccolo, Avet-Loiseau, Hervé, Wedge, David C., Van Loo, Peter, Alexandrov, Ludmil B., Martincorena, Inigo, Dawson, Kevin J., Iorio, Francesco +27 more·2014·Nature Communications

DOI 10.1038/ncomms3997

Cited by (875)

Items 601–700 of 875

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma
Zhiyong Zeng, Jun‐Fang Lin, Kejie Zhang, Xizhe Guo, Xiaoqiang Zheng, Apeng Yang, Junmin Chen · 2021 · Cancer Cell International
Predictors of inferior clinical outcome in patients with standard‐risk multiple myeloma
Talha Badar, Samer Ali Srour, Qaiser Bashir, Nina D. Shah, Gheath Alatrash, Chitra M. Hosing, Uday Popat, Yago L. Nieto, Robert Zygmunt Orlowski, Richard E. Champlin et al. · 2016 · European Journal Of Haematology
Genomic heterogeneity meets cellular energetics: crosstalk between the mitochondria and the cell cycle
Erica L. Herrera, Seham Z. Azzam, Madison C. Berger, Laura A. Díaz-Martínez · 2018 · Journal of Cancer Metastasis and Treatment
Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma
Subodh Kumar, Leutz Buon, Srikanth Talluri, Marco Roncador, Chengcheng Liao, Jiangning Zhao, Jialan Shi, Chandraditya Chakraborty, Gabriel González, Yu‐Tzu Tai et al. · 2021 · Communications Biology
Advancements in Multiple Myeloma Research: High-Throughput Sequencing Technologies, Omics, and the Role of Artificial Intelligence
Alejandra Gutiérrez‐González, Irene del Hierro, Ariel Ernesto Cariaga-Martínez · 2024 · Biology
The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward
Meghana Ram, Molly Fraser, Junia Vieira Dos Santos, Rafail Nikolaos Tasakis, Ariana Islam, Jannah Usama Abo-Donia, Samir Sunil Parekh, Alessandro Laganà · 2024 · Pharmacogenomics and Personalized Medicine
Cancer Genomics in Clinical Context
Lynda Chin, Jennifer Ann Wargo, Denise J. Spring, Hagop M. Kantarjian, P. Andrew Futreal · 2015 · Trends in cancer
Efficacy and safety of Venetoclax-based regimens in relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials
Wei He, Fang He, Huixian Hu · 2023 · Annals of Medicine
FAM46C Is an Interferon-Stimulated Gene That Inhibits Lentiviral Particle Production by Modulating Autophagy
Marilena Mancino, Giancarlo Lai, Federica De Grossi, Alessandro Cuomo, Lara Manganaro, Giacomo M. Butta, Ivan Ferrari, Elisa Vicenzi, Guido Poli, Elisa Pesce et al. · 2023 · Microbiology Spectrum
Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma
Maiia V. Soloveva, Maksim Valerevich Solovev, Natalya Risinskaya, Elena Nikulina, Igor Yakutik, Бидерман Белла Вениаминовна, Т. Н. Обухова, Yulia A. Chabaeva, Sergey M. Kulikov, Andrey Borisovich Sudarikov et al. · 2024 · International Journal of Molecular Sciences
Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets
Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, Minghao Dang, Amishi U. Vora, Li Qin, Hans Chulhee Lee, Krina K. Patel, Pei Lin, David E. Mery et al. · 2025 · Cell Reports Medicine
Modeling disease progression in Multiple Myeloma with Hopfield networks and single-cell RNA-seq
Sergii Domanskyi, Alex Hakansson, Giovanni Paternostro, Carlo Piermarocchi · 2019 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
RAS mutation leading to acquired resistance to dabrafenib and trametinib therapy in a multiple myeloma patient harboring BRAF mutation
Baptiste Le Calvez, Yannick Le Bris, Guillaume Herbreteau, Bastien Jamet, Céline Bossard, Benoît Tessoulin, Thomas Gastinne, Beatrice Mahé, Viviane Dubruille, Nicolas Blin et al. · 2020 · eJHaem
A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
Mariarosaria Sessa, Francesco Cavazzini, Maurizio Cavallari, Gian Matteo Rigolin, Antonio Cuneo · 2020 · Genes
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
Malin L. Hultcrantz, Even Holth Rustad, Venkata D. Yellapantula, Allison P. Jacob, Theresia Akhlaghi, Neha Korde, Sham Mailankody, Alexander M. Lesokhin, Hani Hassoun, Eric L. Smith et al. · 2022 · Clinical Cancer Research
Characterizing the mutational landscape of MM and its precursor MGUS.
Akanksha Farswan, Anubha Gupta, Lingaraja Jena, Vivek Ruhela, Gurvinder Kaur, Ritu Gupta · 2022 · PubMed Central
Molecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma
Chandraditya Chakraborty, Srimoyee Mukherjee · 2022 · Current Oncology
Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTE
Tatsuya Konishi, Toshiki Ochi, Masaki Maruta, Kazushi Tanimoto, Yukihiro Miyazaki, Chika Iwamoto, Takashi Saitou, Takeshi Imamura, Masaki Yasukawa, Katsuto Takenaka · 2023 · Blood
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing
Jonathon H. Gralewski, Ginell Ristic Post, Frits van Rhee, Youzhong Yuan · 2018 · Diagnostic Pathology
Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study
Gurvinder Kaur, Lingaraja Jena, Ritu Gupta, Akanksha Farswan, Anubha Gupta, Krishnamachari Sriram · 2022 · Translational Oncology
Precision medicine in multiple myeloma: are we there yet?
Daniel Auclair, Sagar Lonial, Kenneth Carl Anderson, Shaji Kunnathu Kumar · 2019 · Expert Review of Precision Medicine and Drug Development
Recycling therapies for myeloma: The need for prospective trials
Shaji Kunnathu Kumar · 2019 · Cancer
Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients
Xi Chen, Tiancheng Luo, Wenhui Zhang, Sheng Wang, Mengxuan Zhu, Haiyan He, Jin Liu, Jing Lü, Wanting Qiang, Yanchun Jia et al. · 2025 · BMC Medical Genomics
The numerous facets of 1q21+ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (Review)
Na Liu, Zhanzhi Xie, Hao Li, Luqun Wang · 2024 · Oncology Letters
Bispecific antibodies for multiple myeloma: past, present and future
Toshiki Ochi, Tatsuya Konishi, Katsuto Takenaka · 2024 · International Journal of Hematology
A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex
Bedir, Marisa, Outwin, Emily, Colnaghi, Rita, Bassett, Lydia, Abramowicz, Iga, O’Driscoll, Mark · 2024 · EMBO Reports
Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma
Larissa Haertle, Umair Munawar, Hipólito Nicolás Cuesta Hernández, Andrés Arroyo-Barea, Tobias Heckel, Isabel Cuenca, Lucía Sánchez Martín, Carlotta Höschle, Nicole Müller, Cornelia Vogt et al. · 2024 · HemaSphere
Early monoclonal protein decline pattern is an independent prognostic factor in patients with multiple myeloma
Limei Xu, Junru Liu, Meilan Chen, Lifen Kuang, Beihui Huang, Jingli Gu, Juan Li · 2020 · Annals of Hematology
KRAS , NRAS , and BRAF mutations in plasma cell myeloma at a single Korean institute
Yonggoo Kim, Sung‐Soo Park, Chang‐Ki Min, Dong‐Gun Lee, Jungok Son, Sung Jin Jo, Eunhee Han, Kyungja Han, Myungshin Kim · 2020 · Blood Research
Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy
Fabio Sallustio, Claudia Curci, Antonio Giovanni Solimando, Patrizia Leone, Paola Pontrelli, Loreto Gesualdo, Angelo Vacca, Vito Racanelli, Anna Gallone · 2021 · Cancer Biology & Therapy
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Říhová, Renata Bezděková, David Žihala, Kateřina Growková, Jana Filipová, Lucie Černá et al. · 2021 · Blood Advances
Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma
Ivyna Pau Ni Bong, Ching Ching Ng, Norodiyah Othman, Ezalia Esa · 2022 · Genes & Genomics
Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC
Brian A. Walker · 2018 · Methods in molecular biology
Pharmacodynamic Models of Differential Bortezomib Signaling Across Several Cell Lines of Multiple Myeloma
Vidya Ramakrishnan, Donald E. Mager · 2018 · CPT Pharmacometrics & Systems Pharmacology
Risk-Based Therapeutic Strategies
Jill Corre, Hervé Avet‐Loiseau · 2019 · The Cancer Journal
Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
Ming‐Tseh Lin, Gang Zheng, Li‐Hui Tseng, Peng Zhang, Hua Ling, Nilo Azad, Christopher D. Gocke, Elizabeth Anne Montgomery, James R. Eshleman · 2020 · Human Pathology
The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of multiple myeloma patients
Aleksander Salomon‐Perzyński, Aleksandra Bluszcz, Agnieszka Krzywdzińska, Zofia Spyra-Górny, Natalia Jakacka, Joanna Barankiewicz, Katarzyna Borg, Iwona Solarska, Tomasz Szpila, Bartosz Puła et al. · 2020 · Polskie Archiwum Medycyny Wewnętrznej
The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications
Anna Ewa Pula, Pawel J. Robak, Damian Mikulski, Tadeusz Robak · 2021 · International Journal of Molecular Sciences
Association of Agent Orange With Plasma Cell Disorder
Nikhil C. Munshi · 2015 · JAMA Oncology
Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications
Noa Biran, David H. Vesole, Michèle L. Donato, Andrew Ip, Gurbakhash Kaur, Stuart L. Goldberg, David Samuel DiCapua Siegel · 2020 · Journal of Clinical Oncology
Molecular genetic aberrations in the pathogenesis of multiple myeloma
Ivyna Pau Ni Bong, Ezalia Esa · 2023 · Asian Biomedicine
ABL1 kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma
Subodh Kumar, Srikanth Talluri, Jiangning Zhao, Chengcheng Liao, Lakshmi B. Potluri, Leutz Buon, Shidai Mu, Jialan Shi, Chandraditya Chakraborty, Yu‐Tzu Tai et al. · 2023 · Blood
K-Means Clustering of Hyperpolarised 13C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest Grade
Ines Horvat‐Menih, Alixander S. Khan, Mary Anne McLean, João André Gonçalves Duarte, Eva Mendes Serrão, Stephan Ursprung, Joshua Daniel Kaggie, Andrew B. Gill, Andrew Nicholas Priest, Mireia Crispin‐Ortuzar et al. · 2025 · Cancers
Natural history of liver fluke infection underpins epidemiological patterns of biliary cancer
Thomas Crellen, Francesca Vita, Chiara Braconi, Paiboon Sithithaworn, T. Déirdre Hollingsworth · 2025 · Proceedings of the National Academy of Sciences
European Myeloma Network Group Consensus Statement on the use of next‐generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Niccolò Bolli, Mattia D’Agostino, Tina Bagratuni, Mario Boccadoro, Michèle Cavo, Christoph Driessen, Hermann Einsele, Monika Martha Engelhardt, Francesca Gay, Norma Carmen Gutierrez et al. · 2025 · HemaSphere
CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents
Anna Bögelein, Antje Stolzenburg, Patrick Eiring, Katharina Lückerath, Umair Munawar, Rudolf Alexander Werner, Andreas Schirbel, Samuel Samnick, Klaus Martin Kortüm, Markus Sauer et al. · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers
Antonio Giovanni Solimando, Vanessa Desantis, Matteo Da Vià · 2022 · Methods in molecular biology
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study
Cyril Quivoron, Jean‐Marie Michot, Alina Danu, Hélène Lecourt, Véronique Saada, Khalil Saleh, Véronique Vergé, Sophie Cotteret, Olivier Bernard, Vincent Ribrag · 2024 · Leukemia & lymphoma/Leukemia and lymphoma
Predictive value of pre-treatment circulating tumor DNA genomic landscape in patients with relapsed/refractory multiple myeloma undergoing anti-BCMA CAR-T therapy: Insights from tumor cells and T cells
Rongrong Chen, Chunxiang Jin, Kai Liu, Mengyu Zhao, Tingting Yang, Mingming Zhang, Pingnan Xiao, Jingjing Feng, Ruimin Hong, Shan Fu et al. · 2024 · Chinese Medical Journal
Prognostic indicators of lenalidomide for multiple myeloma: consensus and controversy
Junya Kuroda, Tsutomu Kobayashi, Masafumi Taniwaki · 2015 · Expert Review of Anticancer Therapy
Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma
Sara Ovejero, Jérôme Moreaux · 2021 · Exploration of Targeted Anti-tumor Therapy
Systems approaches to uncovering the contribution of environment-mediated drug resistance
Marc Creixell, Hyuna Kim, Farnaz Mohammadi, Shelly R. Peyton, Aaron S. Meyer · 2022 · Current Opinion in Solid State and Materials Science
Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma
Megan E. Johnstone, Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth Carl Anderson, Annamaria Gullà · 2022 · Cells
Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses
Evan Flietner, Mei Yu, Govinda Poudel, Anthony J. Veltri, Yun Zhou, Adhithi Rajagopalan, Yubin Feng, Terra L. Lasho, Zhi Hong Wen, Yuqian Sun et al. · 2023 · Oncogene
Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level
Ramón García‐Sánz, María García‐Álvarez, Alejandro Medina, Elham Askari, Verónica González‐Calle, María Casanova, Igor de la Torre-Loizaga, Fernando Escalante, Miguel Bastos, Abelardo Bárez et al. · 2023 · Disease Models & Mechanisms
A Review Discussing Elotuzumab and its Use in the Second-Line Plus Treatment of Multiple Myeloma
Massimo Offidani, Laura Corvatta · 2017 · Future Oncology
Plasma Cell Neoplasms
Nikhil C. Munshi, Sundar Jagannath · 2017 · Elsevier eBooks
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia
Jinming Song, Hailing Zhang, Ning C. Dong, Xiaohui Zhang, Mohammad Hussaini, Akriti Gupta Jain, Lynn C. Moscinski, Ken H. Shain, Rachid Baz, Melissa Alsina et al. · 2021 · Clinical Lymphoma Myeloma & Leukemia
The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple Myeloma
Steven M. Prideaux, Emma Conway O’Brien, Timothy J. T. Chevassut · 2014 · Bone Marrow Research
RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells
Chengcheng Liao, Jiangning Zhao, Subodh Kumar, Chandraditya Chakraborty, Srikanth Talluri, Nikhil C. Munshi, Masood A. Shammas · 2020 · Archives of Clinical Toxicology
Patient Similarity Network of Multiple Myeloma Identifies Patient Sub-groups with Distinct Genetic and Clinical Features
Sherry Bhalla, David T. Melnekoff, Jonathan J. Keats, Kenan Onel, Deepu Madduri, Joshua Ryan Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Joel T. Dudley et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data
Mohammad Salma, Elina Alaterre, Jérôme Moreaux, Éric Soler · 2023 · Epigenetics & Chromatin
Genomes and epigenomes of matched normal and tumor breast tissue reveal diverse evolutionary trajectories and tumor-host interactions
Bin Zhu, Avraam Tapinos, Hela Koka, Priscilla Ming Yi Lee, Tongwu Zhang, Wei Zhong Zhu, Xiaoyu Wang, Alyssa Klein, DongHyuk Lee, Gary Man-Kit Tse et al. · 2024 · The American Journal of Human Genetics
A systematic literature review on clonal evolution events preceding relapse in multiple myeloma
Maja Zimmer Jakobsen, Rasmus Froberg Brøndum, Henrik Gregersen, Hanne Due, Karen Dybkær · 2024 · Critical Reviews in Oncology/Hematology
MIR4726EccDNA drives bortezomib resistance in multiple myeloma by enhancing MIR4726-5p/NXF1/NKIRAS2 axis dependent autophagy
Fangfang Li, Xinyi Long, Sishi Tang, Jinhua Yan, Jing Liu, Yunfeng Fu · 2025 · Cell Communication and Signaling
Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization
Awais Ali · 2025 · Current Medical Science
How I treat plasma cell leukemia
Samer Al Hadidi, Frits van Rhee, Larry D. Anderson · 2026 · Blood
Liquid Biopsy in Multiple Myeloma
Sridurga Mithraprabhu, Andrew G Spencer · 2018 · InTech eBooks
Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma
Juxian Tang, Jia-Hui Zhang, Kebing Zhou, Wangting Li, Jinying Wang, Qin Li, Fengxia Yan, Duan Xiao · 2022 · Neoplasma
Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma—A Pilot Study
Lorenz Oelschläger, Axel Künstner, Friederike Frey, Theo Leitner, Lisa Beatrice Leypoldt, Niklas Reimer, Niklas Gebauer, Lorenz Bastian, Katja Christina Weisel, Verena‐Wilbeth Sailer et al. · 2024 · International Journal of Molecular Sciences
Spatial deconvolution from bulk DNA methylation profiles determines intratumoral epigenetic heterogeneity
Binbin Liu, Yumo Xie, Yu Zhang, Guannan Tang, Jinxin Lin, Ze Yuan, Xiaoxia Liu, Xiaolin Wang, Meijin Huang, Yanxin Luo et al. · 2025 · Cell & Bioscience
Genetic Intratumor Heterogeneity
Donát Alpár, Louise J. Barber, Marco Gerlinger · 2015 · Elsevier eBooks
Vision Statement for Multiple Myeloma: Future Directions
Kenneth Carl Anderson · 2016 · Cancer treatment and research
Covariate-Assisted Bayesian Graph Learning for Heterogeneous Data
Yabo Niu, Yang Ni, Debdeep Pati, Bani K. Mallick · 2023 · Journal of the American Statistical Association
Medical Image Analysis of Multiple Myeloma Diagnosis Using CNN and KNN Based Approach
M Sakthivel, Md. Sakiul Islam Sudman, K. Ravishankar, Bhagyalakshmi Avinash, Anup Kumar, Muruganantham Ponnusamy · 2023 · International Conference on Self Sustainable Artificial Intelligence Systems (ICSSAS)
Clinical impact of MYC abnormalities in plasma cell myeloma
Rolando García, Weina Chen, Prasad R. K. Koduru · 2018 · Cancer Genetics
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice
Natasha Friend, Jacqueline E. Noll, Khatora S. Opperman, Kimberley C. Clark, Krzysztof Marek Mrozik, Kate Vandyke, Duncan R. Hewett, Andrew C.W. Zannettino · 2020 · PLoS ONE
Developments in consolidation and maintenance strategies in post-remission multiple myeloma
Sonia Morè, Laura Corvatta, Laura Maracci, Benedetta Costantini, Attilio Olivieri, Massimo Offidani · 2020 · Expert Review of Hematology
PhyDOSE: Design of follow-up single-cell sequencing experiments of tumors
Leah L. Weber, Nuraini Aguse, Nicholas Chia, Mohammed El-Kebir · 2020 · PLoS Computational Biology
Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population
Chutirat Jirabanditsakul, Sumana Dakeng, Chutima Kunacheewa, Yaowalak U‐pratya, Weerapat Owattanapanich · 2022 · Technology in Cancer Research & Treatment
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
Sarah Sandmann, Katharina Karsch, Peter Bartel, Rita Exeler, Tobias Johannes Brix, Elias K. Mai, Julian Varghese, Georg Lenz, Cyrus Khandanpour · 2022 · Frontiers in Oncology
Correlation of plasma cell assessment by phenotypic methods and molecular profiles by NGS in patients with plasma cell dyscrasias
Ekaterina Rebmann Chigrinova, Naomi Azur Porret, Martin Andres, Gertrud Wiedemann, Yara Banz, Myriam Legros, Matthias Pollak, Elisabeth Oppliger Leibundgut, Thomas Pabst, Ulrike Bacher · 2022 · BMC Medical Genomics
FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma
Weilong Zhang, Chaoling Wu, Shuang Geng, Jing Wang, Changjian Yan, Xiannian Zhang, Jiajia Zhang, Fan Wu, Yuhong Pang, Yuping Zhong et al. · 2023 · Aging
Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology
Daniele Dall’Olio, Eric Sträng, Amin T. Turki, Jesse Marc Tettero, Martje Barbus, Renate Schulze‐Rath, Javier Martinez Martínez Elicegui, Tommaso Matteuzzi, Alessandra Merlotti, Luciana Carota et al. · 2024 · PLoS Computational Biology
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms
Jacob Jahn, Benjamin T. Diamond, Jeffrey Hsu, Skye Montoya, Tulasigeri M. Totiger, Ola Landgren, Francesco Maura, Justin Taylor · 2023 · Leukemia Research
Plasma Cell Myeloma: Biochemical Insights into Diagnosis, Treatment, and Smart Nanocarrier-Based Therapeutic Development
Lizeth Geraldine Muñoz, Sixta Palencia Luna, Andrés Felipe Chamorro · 2025 · Pharmaceutics
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Alfredo Marchetti, Sonia Fabris, Stefania Pioggia, Ilaria Silvestris, Domenica Ronchetti et al. · 2024 · Blood Advances
Reconstructing oral cavity tumor evolution through brush biopsy
Evit John, Tom Lesluyes, Toby M. Baker, Maxime Tarabichi, Ann Marie Gillenwater, Jennifer Rui Wang, Peter Van Loo, Xiao Ling Zhao · 2024 · Scientific Reports
DMG26
Samuel D. Cutler, Philipp Knopf, Clinton J.V. Campbell, Andrea J. Thoni, Mohamed Abou El Hassan, Nicholas Allen Forward, Darrell J. White, Julie Wagner, Marissa Goudie, Jeanette E. Boudreau et al. · 2021 · Journal of Molecular Diagnostics
Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value
Jun Du, Xiao-Ran Gu, Xiaoxiao Yu, Yang-Jia Cao, Jian Hou · 2023 · Blood Science
Resistance Mechanisms to Novel Therapies in Myeloma
Craig Thomas Wallington-Beddoe, Douglas W. Coghlan · 2019 · IntechOpen eBooks
Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma
Yansheng Hao, Daniel Khaykin, Levi Machado, Tayler A. van den Akker, Jane Houldsworth, Bart Barlogie, Shafinaz Hussein, Siraj M. El Jamal, Bruce E. Petersen, Julie Teruya‐Feldstein · 2019 · Modern Pathology
The clonal evolution during long-term clinical course of multiple myeloma
Yuko Matsumoto Mishima, Yuji Mishima, Yuko Shirouchi, Noriko Nishimura, Masahiro Yokoyama, Takashi Okabe, Norihito Inoue, Hideki Uryu, Takanori Fukuta, Kiyohiko Hatake et al. · 2020 · International Journal of Hematology
Patient Similarity Network of Multiple Myeloma Identifies Patient Subgroups with Distinct Genetic and Clinical Features
Sherry Bhalla · 2020 · 62nd ASH Annual Meeting and Exposition
Molecular Diagnostics of Plasma Cell Neoplasms
Megan J. Fitzpatrick, Mandakolathur R. Murali, Valentina Nardi · 2023 · Surgical pathology clinics
t(11;14) status is stable between diagnosis and relapse and concordant between detection methodologies based on fluorescence in situ hybridization and next-generation sequencing in patients with multiple myeloma
Hervé Avet‐Loiseau, Raphaële Thiébaut-Millot, Xiaotong Li, Jeremy A. Ross, Carlos Hader · 2023 · Haematologica
Intratumor Heterogeneity and Transcriptional Profiling in Glioblastoma: Translational Opportunities
Sara G. M. Piccirillo, Inmaculada Spiteri · 2015 · Future Neurology
Section II: Hematolymphoid malignancies
Linsheng Zhang, Michael R. Rossi, Kevin E. Fisher · 2014 · Current Problems in Cancer
Next-Generation Sequencing in Multiple Myeloma: Insights into the Molecular Heterogeneity of the Disease
Luca Agnelli, Antonino Neri · 2014 · International Journal of Hematologic Oncology
Rapid parallel acquisition of somatic mutations after NPM 1 in acute myeloid leukaemia evolution
Carolyn S. Grove, Niccolò Bolli, Nicla Manes, Ignacio Varela, Mars B. vanʼt Veer, Anthony J. Bench, Hesham Eldaly, David C. Wedge, Peter Van Loo, George S. Vassiliou · 2016 · British Journal of Haematology